| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 35.239 | 46.068 | 55.331 | 49.652 | 46.479 | 48.400 | 55.624 | 67.541 | 68.101 |
| Total Income - EUR | - | 36.255 | 46.270 | 59.261 | 49.728 | 46.894 | 48.492 | 56.213 | 67.933 | 76.865 |
| Total Expenses - EUR | - | 33.387 | 39.127 | 49.823 | 43.406 | 42.663 | 38.590 | 44.487 | 44.377 | 55.967 |
| Gross Profit/Loss - EUR | - | 2.868 | 7.143 | 9.438 | 6.322 | 4.230 | 9.902 | 11.725 | 23.556 | 20.897 |
| Net Profit/Loss - EUR | - | 2.506 | 6.301 | 8.846 | 5.828 | 3.763 | 9.414 | 11.164 | 22.877 | 19.728 |
| Employees | - | 3 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Icodali Doc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 3.144 | 7.641 | 14.695 | 11.610 | 7.439 | 4.038 | 2.021 | 9.153 | 29.779 |
| Current Assets | - | 5.595 | 10.273 | 16.866 | 20.339 | 24.306 | 29.748 | 33.963 | 33.908 | 11.769 |
| Inventories | - | 232 | 367 | 98 | 1.256 | 654 | 897 | 669 | 335 | 237 |
| Receivables | - | 1.215 | 320 | 569 | 641 | 461 | 1.019 | 9.683 | 3.336 | 4.674 |
| Cash | - | 4.147 | 9.586 | 16.200 | 18.442 | 23.191 | 27.832 | 23.611 | 30.237 | 6.859 |
| Shareholders Funds | - | 2.550 | 6.353 | 10.184 | 11.389 | 14.936 | 19.774 | 11.213 | 27.414 | 19.776 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.188 | 11.561 | 21.378 | 20.559 | 16.809 | 14.012 | 24.771 | 15.647 | 21.833 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9510 - 9510" | |||||||||
| CAEN Financial Year |
9511
|
|||||||||
Comments - Icodali Doc S.r.l.